Trials / Completed
CompletedNCT05814809
Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers
Phase I Study to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Onconic Therapeutics Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and the pharmacokinetics of the JP-1366 20 mg tablet and capsule oral administration in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JP-1366 20mg tablet | T : JP-1366 20mg tablet |
| DRUG | JP-1366 20mg capsule | R : JP-1366 20mg capsule |
Timeline
- Start date
- 2022-09-30
- Primary completion
- 2022-10-09
- Completion
- 2022-11-09
- First posted
- 2023-04-18
- Last updated
- 2023-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05814809. Inclusion in this directory is not an endorsement.